Steven Marotta
Stock Analyst at CL King
(0.38)
# 3,178
Out of 4,497 analysts
9
Total ratings
37.5%
Success rate
-15.08%
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $25.54 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $43.80 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | n/a | $6.15 | - | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | n/a | $20.85 | - | 1 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | n/a | $34.02 | - | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $133.50 | - | 1 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $27.20 | - | 2 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $25.54
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $43.80
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: n/a
Current: $6.15
Upside: -
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: n/a
Current: $20.85
Upside: -
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: n/a
Current: $34.02
Upside: -
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $133.50
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $27.20
Upside: -